Accéder au contenu
Merck

Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.

Mini reviews in medicinal chemistry (2008-03-14)
M E Meza-Avina, L Wei, M G Buhendwa, E Poduch, A M Bello, E F Pai, L P Kotra
RÉSUMÉ

Orotidine 5'-monophosphate decarboxylase (ODCase) is among the most proficient enzymes, and catalyzes the decarboxylation of OMP to UMP. An overview of ODCase and various proposals for its catalytic mechanism of decarboxylation are briefly presented here. A number of inhibitors of ODCase and new developments in the X-ray structures of ODCases from different species are discussed in the context of their therapeutic potential against cancer and infectious diseases. Latest discoveries in the inhibition of ODCase, for example using the novel C6 substitutions on the uridine, open new doors for drug discovery targeting parasitic diseases such as malaria.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Orotidine 5′-monophosphate trisodium salt, ≥99% (HPLC), powder